In vitro functional characterization of 37 CYP2C9 allelic isoforms found in Chinese Han population

被引:54
作者
Dai, Da-peng [1 ,2 ]
Wang, Yu-han [3 ]
Wang, Shuang-hu [4 ]
Geng, Pei-wu [4 ]
Hu, Li-ming [4 ]
Hu, Guo-xin [4 ]
Cai, Jian-ping [1 ,2 ]
机构
[1] Beijing Hosp, Key Lab Geriatr, Beijing 100730, Peoples R China
[2] Beijing Inst Geriatr, Minist Hlth, Beijing 100730, Peoples R China
[3] Shandong Univ, Coll Med, Jinan 250012, Peoples R China
[4] Wenzhou Med Univ, Dept Pharmacol, Wenzhou 325035, Peoples R China
关键词
CYP2C9; allelic variants; drug metabolism; tolbutamide; Chinese Han population; DEFECTIVE ALLELES; 2C9; GENE; VARIANTS; CYTOCHROME-P450; POLYMORPHISM; JAPANESE; METABOLISM; ASIANS;
D O I
10.1038/aps.2013.123
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Aim: Cytochrome P450 2C9 (CYP2C9) is a polymorphic enzyme that is responsible for the metabolism of approximately 15% of clinically important drugs. The aim of this study was to assess the catalytic characteristics of 37 CYP2C9 allelic isoforms found in Chinese Han population on the metabolism of tolbutamide in vitro. Methods: The wild-type and 36 CYP2C9 variants were expressed in sf21 insect cells using a baculovirus-mediated expression system. Then the insect microsomes were prepared for assessing the metabolic characteristics of each variant toward the CYP2C9-specific drug substrate tolbutamide. Results: Of 36 allelic variants tested, the intrinsic clearance values of 2 allelic isoforms (CYP2C9.36 and CYP2C9.51) were much higher than the wild-type CYP2C9.1 protein, 3 allelic isoforms (CYP2C9.11, CYP2C9.56 and N418T) exhibited similar intrinsic clearance values as the wild-type enzyme, whereas the other 31 variants showed significantly reduced intrinsic clearance values, ranging from 0.08% to 66.88%, for tolbutamide. Conclusion: Our study provides the most comprehensive data concerning the enzymatic activity of the CYP2C9 variants that are present in the Chinese Han population, and our data suggest that most of the carriers of these alleles might be paid more attention when using CYP2C9 mediated drugs clinically.
引用
收藏
页码:1449 / 1456
页数:8
相关论文
共 27 条
[1]   CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population [J].
Allabi, AC ;
Gala, JL ;
Horsmans, Y .
PHARMACOGENETICS AND GENOMICS, 2005, 15 (11) :779-786
[2]   Allele and genotype frequencies of CYP2C9 in a Korean population [J].
Bae, JW ;
Kim, HK ;
Kim, JH ;
Yang, SI ;
Kim, MJ ;
Jang, CG ;
Park, YS ;
Lee, SY .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (04) :418-422
[3]   Discovery of new potentially defective alleles of human CYP2C9 [J].
Blaisdell, J ;
Jorge-Nebert, LF ;
Coulter, S ;
Ferguson, SS ;
Lee, SJ ;
Chanas, B ;
Xi, T ;
Mohrenweiser, H ;
Ghanayem, B ;
Goldstein, JA .
PHARMACOGENETICS, 2004, 14 (08) :527-537
[4]   CYP2C9 polymorphism analysis in Han Chinese populations: building the largest allele frequency database [J].
Dai, D-P ;
Xu, R-A ;
Hu, L-M ;
Wang, S-H ;
Geng, P-W ;
Yang, J-F ;
Yang, L-P ;
Qian, J-C ;
Wang, Z-S ;
Zhu, G-H ;
Zhang, X-H ;
Ge, R-S ;
Hu, G-X ;
Cai, J-P .
PHARMACOGENOMICS JOURNAL, 2014, 14 (01) :85-92
[5]   Functional characterization of novel allelic variants of CYP2C9 recently discovered in southeast Asians [J].
DeLozier, TC ;
Lee, SC ;
Coulter, SJ ;
Goh, BC ;
Goldstein, JA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (03) :1085-1090
[6]   Catalytic activities of human cytochrome P4502C9*1, 2C9*3 and 2C9*13 [J].
Guo, Y ;
Wang, Y ;
Si, D ;
Fawcett, PJ ;
Zhong, D ;
Zhou, H .
XENOBIOTICA, 2005, 35 (09) :853-861
[7]   No major difference in inhibitory susceptibility between CYP2C9.1 and CYP2C9.3 [J].
Hanatani, T ;
Fukuda, T ;
Onishi, S ;
Funae, Y ;
Azuma, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (03) :233-235
[8]   Characterization of the novel defective CYP2C9*24 allele [J].
Herman, Darja ;
Dolzan, Vita ;
Ingelman-Sundberg, Magnus .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (06) :831-834
[9]   In Vitro Assessment of the Allelic Variants of Cytochrome P450 [J].
Hiratsuka, Masahiro .
DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (01) :68-84
[10]   Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese epileptic patients:: genetic analysis of the CYP2C9 locus [J].
Imai, J ;
Ieiri, I ;
Mamiya, K ;
Miyahara, S ;
Furuumi, H ;
Nanba, E ;
Yamane, M ;
Fukumaki, Y ;
Ninomiya, H ;
Tashiro, N ;
Otsubo, K ;
Higuchi, S .
PHARMACOGENETICS, 2000, 10 (01) :85-89